Narcolepsy

The Pharmaceutical Benefits Scheme subsidises modafinil and armodafinil for patients with narcolepsy.

For patients with narcolepsy, treatment with modafinil and armodafinil can be subsidised through the PBS under section 85 of the National Health Act 1953.

Restriction details

Modafinil and armodafinil are not PBS subsidised when used in combination with each other or with PBS subsidised dexamphetamine sulfate.

Application requirements

Initial treatment

All applications for initial treatment must be made by a qualified sleep medicine practitioner or a neurologist.

Continuing treatment

Continuing treatment of narcolepsy, where the patient has previously been issued with an authority prescription for these medicines, can be requested by the patient's medical practitioner. Applications for continuing treatment may be requested by contacting the PBS Complex Drugs Programs enquiry line.

Patient eligibility

Patients must meet the relevant criteria as indicated in the restrictions and be eligible for the PBS.

Lodging an application

Make sure all written applications for initial PBS authorisation include:

All applications for continuing approvals may be made by medical practitioners by contacting the PBS Complex Drugs Programs enquiry line.

Send all written applications to the PBS Complex Drugs Programs address.

Further information

For more information contact the PBS Complex Drugs Programs enquiry line.

Page last updated: 8 November 2016

This information was printed Sunday 4 December 2016 from humanservices.gov.au/health-professionals/enablers/narcolepsy It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.